Patients Should Be Warned of Testosterone Risks

Dr Gerald Chodak discusses an FDA panel's recommendation to change labels on testosterone-replacement products in order to discourage their use in 'low T' cases.

Source: Medscape Diabetes & Endocrinology Podcast - October 7, 2014 Category: Endocrinology Authors: Medscape Source Type: podcasts